K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines.
暂无分享,去创建一个
G. Capellá | P. Pour | M. Cuatrecasas | F. Sancho | F. Lluís | A. Farré | N. Erill
[1] A. Gazdar,et al. High yields of Kras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by iV-nitroso ( 2-hydroxypropyl ) ( 2-oxopropyl ) amine in the pancreas of female Syrian hamsters , 2005 .
[2] Y. Konishi,et al. p53 mutation without allelic loss and absence of mdm‐2 amplification in a transplantable hamster pancreatic ductal adenocarcinoma and derived cell lines but not primary ductal adenocarcinomas in hamsters , 1995, Molecular carcinogenesis.
[3] S. Hubchak,et al. Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas. , 1995, Cancer research.
[4] H. Futami,et al. The role of angiogenesis in the tumor growth of Syrian hamster pancreatic cancer cell line HPD-NR. , 1995, Gastroenterology.
[5] F. Suzuki,et al. Characterization of three cloned cell lines from aN-nitrosobis(2-hydroxypropyl)amine-induced transplantable hamster pancreatic ductal adenocarcinoma , 1994, International journal of pancreatology : official journal of the International Association of Pancreatology.
[6] R. Hruban,et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma , 1994, Nature Genetics.
[7] S. Hubchak,et al. Genomic p53 mutation in a chemically induced hamster pancreatic ductal adenocarcinoma. , 1994, Cancer research.
[8] B. Simon,et al. Frequent alterations of the tumor suppressor genes p53 and DCC in human pancreatic carcinoma. , 1994, Gastroenterology.
[9] E. Musulen,et al. p53 expression in anaplastic carcinomas arising from thyroid papillary carcinomas. , 1994, Journal of clinical pathology.
[10] P. Pour,et al. Comparison of p53 protein expression and cellular localization in human and hamster pancreatic cancer cell lines. , 1993, Carcinogenesis.
[11] S. Goodman,et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. , 1993, The American journal of pathology.
[12] H. Yonekawa,et al. No allelic loss at the p53 locus in 1,2-dimethylhydrazine-induced mouse colon tumours: PCR-SSCP analysis with sequence-tagged microsatellite site primers. , 1993, Carcinogenesis.
[13] G. Lauer,et al. p53 and K-RAS alterations in pancreatic epithelial cell lesions. , 1993, Oncogene.
[14] A. Rizzino,et al. Production of scatter factor-like activity by a nitrosamine-induced pancreatic cancer cell line. , 1993, Carcinogenesis.
[15] K. Mangold,et al. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. , 1992, Cancer research.
[16] T. Soussi,et al. The cDNA cloning and immunological characterization of hamster p53. , 1992, Gene.
[17] P. Hall,et al. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. , 1991, British Journal of Cancer.
[18] R. Woutersen,et al. Activation of c-K-ras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats. , 1991, Carcinogenesis.
[19] G. Capellá,et al. Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. , 1991, Environmental health perspectives.
[20] P. Pour,et al. Patterns of growth and metastases of induced pancreatic cancer in relation to the prognosis and its clinical implications. , 1991, Gastroenterology.
[21] K. Mangold,et al. Activation of K-ras in transplantable pancreatic ductal adenocarcinomas of Syrian golden hamsters. , 1990, Carcinogenesis.
[22] G. Capellá,et al. Mutational activation of the c-K-ras gene in human pancreatic carcinoma. , 1990, Bailliere's clinical gastroenterology.
[23] P. Pour,et al. Establishment of hamster pancreatic ductal carcinoma cell line (PC-1) producing blood group-related antigens. , 1989, Carcinogenesis.
[24] D. Shibata,et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.
[25] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[26] A. Balmain,et al. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis , 1986, Nature.
[27] C. Townsend,et al. Development of a transplantable model of pancreatic duct adenocarcinoma. , 1982, Surgery.
[28] J. Schweizer,et al. p53 mutations are absent from carcinogen‐induced mouse liver tumors but occur in cell lines established from these tumors , 1992, Molecular carcinogenesis.
[29] P. Gumerlock,et al. Mutational analysis of a dominant oncogene (c‐Ki‐ras‐2) and a tumor suppressor gene (p53) in hamster lung tumorigenesis , 1992, Molecular carcinogenesis.
[30] 藤井 秀樹. Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12 , 1992 .
[31] B Budowle,et al. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. , 1991, American journal of human genetics.
[32] P. Pour,et al. Pancreatic ductal adenocarcinomas induced in syrian hamsters by N‐nitrosobis (2‐oxopropyl) amine contain a c‐Ki‐ras oncogene with a point‐mutated codon 12 , 1990, Molecular carcinogenesis.
[33] P. Pour. Experimental pancreatic cancer. , 1989, The American journal of surgical pathology.